Puma Biotechnology (PBYI)
(Delayed Data from NSDQ)
$2.54 USD
+0.10 (4.10%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $2.54 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth A Momentum A VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/7/24 |
---|---|
Current Quarter | 0.30 |
EPS Last Quarter | -0.05 |
Last EPS Surprise | 50.00% |
ABR | 3.00 |
Earnings ESP
|
25.28% |
---|---|
Current Year | 0.42 |
Next Year | 0.43 |
EPS (TTM) | 0.38 |
P/E (F1) | 6.05 |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 71.30M | 63.30M | 217.68M | 235.97M |
# of Estimates | 1 | 2 | 2 | 3 |
High Estimate | 71.30M | 72.90M | 219.46M | 244.00M |
Low Estimate | 71.30M | 53.70M | 215.90M | 227.10M |
Year ago Sales | 56.10M | 72.20M | 235.70M | 217.68M |
Year over Year Growth Est. | 27.09% | -12.33% | -7.65% | 8.40% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.30 | 0.23 | 0.42 | 0.43 |
# of Estimates | 3 | 2 | 3 | 3 |
Most Recent Consensus | 0.45 | 0.08 | 0.43 | NA |
High Estimate | 0.45 | 0.37 | 0.44 | 0.74 |
Low Estimate | 0.15 | 0.08 | 0.39 | 0.15 |
Year ago EPS | 0.17 | 0.31 | 0.67 | 0.42 |
Year over Year Growth Est. | 76.47% | -25.81% | -37.31% | 3.17% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 0 | 1 | 1 |
Up Last 60 Days | 1 | 0 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 1 | 0 | 1 |
Down Last 60 Days | 0 | 1 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.30 | 0.23 | 0.42 | 0.43 |
7 Days Ago | 0.30 | 0.23 | 0.42 | 0.43 |
30 Days Ago | 0.13 | 0.40 | 0.40 | 0.48 |
60 Days Ago | 0.13 | 0.40 | 0.40 | 0.48 |
90 Days Ago | 0.13 | 0.40 | 0.40 | 0.48 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.38 | 0.08 | 0.43 | 0.45 |
Zacks Consensus Estimate | 0.30 | 0.23 | 0.42 | 0.43 |
Earnings ESP | 25.28% | -64.44% | 2.38% | 2.69% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.05 | -0.05 | 0.31 | 0.17 | NA |
Estimate | -0.10 | -0.16 | 0.37 | 0.15 | NA |
Difference | 0.05 | 0.11 | -0.06 | 0.02 | 0.03 |
Surprise | 50.00% | 68.75% | -16.22% | 13.33% | 28.97% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more